Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Nuclear Receptors Meta-Pathway WP2882	6/319	0.0013459259854368762	0.13265562291767594	0	0	5.3704244637151985	35.50212020383874	SLC5A6;TGFB2;ALAS1;SCD;PTGR1;EPHA2
NRF2 pathway WP2884	4/146	0.0023269386884749543	0.13265562291767594	0	0	7.73943661971831	46.92576560168329	SLC5A6;TGFB2;PTGR1;EPHA2
Fatty Acid Biosynthesis WP357	2/22	0.003133597391756124	0.13265562291767594	0	0	26.897297297297296	155.0783474227624	SCD;HADH
Retinoblastoma gene in cancer WP2446	3/87	0.004445836066787023	0.14115529512048797	0	0	9.706457925636007	52.56811191289744	CDC45;RRM2;RPA1
DNA Replication WP466	2/42	0.011121341657353713	0.23741539683623286	0	0	13.435135135135136	60.44318630537966	CDC45;RPA1
Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718	2/46	0.013238936206266351	0.23741539683623286	0	0	12.211302211302211	52.80891302442309	SCD;HMGCS2
Synthesis and Degradation of Ketone Bodies WP311	1/5	0.01885787265075893	0.23741539683623286	0	0	66.4	263.6627670535498	HMGCS2
G1 to S cell cycle control WP45	2/64	0.024681803928473307	0.23741539683623286	0	0	8.658238884045335	32.05010754891044	CDC45;RPA1
PPAR signaling pathway WP3942	2/67	0.026872841041134646	0.23741539683623286	0	0	8.257380457380457	29.863965266146195	SCD;HMGCS2
ATR Signaling WP3875	1/9	0.0336911821161097	0.23741539683623286	0	0	33.193333333333335	112.54263179248726	RPA1
Urea cycle and related diseases WP4571	1/9	0.0336911821161097	0.23741539683623286	0	0	33.193333333333335	112.54263179248726	ASL
Heme Biosynthesis WP561	1/9	0.0336911821161097	0.23741539683623286	0	0	33.193333333333335	112.54263179248726	ALAS1
Joubert Syndrome WP4656	2/76	0.033892342835198215	0.23741539683623286	0	0	7.24981738495252	24.537486624824087	TCTN3;FLNA
DNA IR-damage and cellular response via ATR WP4016	2/80	0.03721720307227453	0.23741539683623286	0	0	6.876645876645877	22.630932766884165	CDC45;RPA1
Liver X receptor pathway WP2874	1/10	0.0373647978046119	0.23741539683623286	0	0	29.503703703703703	96.97944863399397	SCD
Alanine and aspartate metabolism WP106	1/12	0.04467073326473782	0.23741539683623286	0	0	24.136969696969697	75.02824312324114	ASL
Bile acids synthesis and enterohepatic circulation  WP4389	1/12	0.04467073326473782	0.23741539683623286	0	0	24.136969696969697	75.02824312324114	FGFR4
Biomarkers for urea cycle disorders WP4583	1/12	0.04467073326473782	0.23741539683623286	0	0	24.136969696969697	75.02824312324114	ASL
Androgen receptor signaling pathway WP138	2/90	0.04604479477336015	0.23741539683623286	0	0	6.092137592137592	18.75245580061792	FLNA;FKBP4
Amino Acid metabolism WP3925	2/91	0.04696623705493484	0.23741539683623286	0	0	6.023382933495293	18.42147041608476	HMGCS2;HADH
Homologous recombination WP186	1/13	0.04830315471494212	0.23741539683623286	0	0	22.124444444444446	67.04278374363157	RPA1
Omega-9 FA synthesis WP4724	1/14	0.05192194616352185	0.23741539683623286	0	0	20.42153846153846	60.40719102216577	SCD
Pathways Regulating Hippo Signaling WP4540	2/98	0.05360252430785276	0.23741539683623286	0	0	5.582207207207207	16.33442651078147	FGFR4;EPHA2
Biomarkers for pyrimidine metabolism disorders WP4584	1/15	0.05552715802056815	0.23741539683623286	0	0	18.961904761904762	54.81664896212504	RRM2
SREBF and miR33 in cholesterol and lipid homeostasis WP2011	1/16	0.059118840526939886	0.23741539683623286	0	0	17.69688888888889	50.05044051882733	SCD
Sulfation Biotransformation Reaction WP692	1/17	0.06269704374316237	0.23741539683623286	0	0	16.59	45.94502588618206	PAPSS2
Mitochondrial LC-Fatty Acid Beta-Oxidation WP368	1/17	0.06269704374316237	0.23741539683623286	0	0	16.59	45.94502588618206	HADH
Platelet-mediated interactions with vascular and circulating cells WP4462	1/17	0.06269704374316237	0.23741539683623286	0	0	16.59	45.94502588618206	TGFB2
Pyrimidine metabolism and related diseases WP4225	1/17	0.06269704374316237	0.23741539683623286	0	0	16.59	45.94502588618206	RRM2
Proteoglycan biosynthesis WP4784	1/18	0.06626181755179136	0.23741539683623286	0	0	15.613333333333333	42.376795202067306	PAPSS2
MAPK Signaling Pathway WP382	3/246	0.06722196297176802	0.23741539683623286	0	0	3.328428885506511	8.98594337425135	TGFB2;FLNA;FGFR4
Apoptosis Modulation by HSP70 WP384	1/19	0.06981321167142542	0.23741539683623286	0	0	14.745185185185186	39.25068041075836	APAF1
Nucleotide metabolism WP404	1/19	0.06981321167142542	0.23741539683623286	0	0	14.745185185185186	39.25068041075836	RRM2
Imatinib and Chronic Myeloid Leukemia WP3640	1/20	0.0733512756104792	0.23741539683623286	0	0	13.968421052631578	36.49243551909278	PIM1
Nanomaterial induced apoptosis WP2507	1/20	0.0733512756104792	0.23741539683623286	0	0	13.968421052631578	36.49243551909278	APAF1
Hypertrophy Model WP516	1/20	0.0733512756104792	0.23741539683623286	0	0	13.968421052631578	36.49243551909278	CYR61
Cell cycle WP179	2/120	0.07638836560652136	0.23741539683623286	0	0	4.536417773705909	11.667325724854228	TGFB2;CDC45
Hippo-Merlin Signaling Dysregulation WP4541	2/120	0.07638836560652136	0.23741539683623286	0	0	4.536417773705909	11.667325724854228	FGFR4;EPHA2
Urea cycle and metabolism of amino groups WP497	1/21	0.07687605873194113	0.23741539683623286	0	0	13.269333333333334	34.043281187726755	ASL
Host-pathogen interaction of human coronaviruses - apoptosis WP4864	1/21	0.07687605873194113	0.23741539683623286	0	0	13.269333333333334	34.043281187726755	APAF1
VEGFA-VEGFR2 Signaling Pathway WP3888	4/432	0.08214905749173364	0.23741539683623286	0	0	2.530633437175493	6.324609464978364	TMOD1;RCAN1;CYR61;EPHA2
DNA Mismatch Repair WP531	1/23	0.08388597903749243	0.23741539683623286	0	0	12.061818181818182	29.892765337545285	RPA1
Urea cycle and associated pathways WP4595	1/24	0.0873712140350116	0.23741539683623286	0	0	11.536811594202899	28.122009760714384	ASL
miRNA regulation of p53 pathway in prostate cancer WP3982	1/24	0.0873712140350116	0.23741539683623286	0	0	11.536811594202899	28.122009760714384	APAF1
22q11.2 copy number variation syndrome WP4657	2/131	0.0887414943260991	0.23741539683623286	0	0	4.147286821705427	10.044843536296465	XPO1;CDC45
Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668	1/25	0.09084336383222283	0.23741539683623286	0	0	11.055555555555555	26.518060438580466	FLNA
Glucuronidation WP698	1/26	0.09430247690616043	0.23741539683623286	0	0	10.6128	25.05945090071607	UGDH
Interactions between immune cells and microRNAs in tumor microenvironment WP4559	1/28	0.10118178586647288	0.23741539683623286	0	0	9.82567901234568	22.509024314139115	TGFB2
Selective expression of chemokine receptors during T-cell polarization WP4494	1/29	0.10460207779228121	0.23741539683623286	0	0	9.474285714285715	21.389070339886597	TGFB2
Eicosanoid metabolism via lipooxygenases (LOX) WP4721	1/29	0.10460207779228121	0.23741539683623286	0	0	9.474285714285715	21.389070339886597	PTGR1
Eicosanoid metabolism via cyclooxygenases (COX) WP4719	1/30	0.10800952509913052	0.23741539683623286	0	0	9.14712643678161	20.3572579045293	PTGR1
Extracellular vesicle-mediated signaling in recipient cells WP2870	1/30	0.10800952509913052	0.23741539683623286	0	0	9.14712643678161	20.3572579045293	TGFB2
Ethanol effects on histone modifications WP3996	1/31	0.11140417537718053	0.23741539683623286	0	0	8.841777777777779	19.40408125999615	ALDH1A3
Gastric Cancer Network 2 WP2363	1/31	0.11140417537718053	0.23741539683623286	0	0	8.841777777777779	19.40408125999615	UBE2T
Hepatitis B infection WP4666	2/152	0.11378925738446663	0.23741539683623286	0	0	3.562882882882883	7.743595170848438	TGFB2;APAF1
Constitutive Androstane Receptor Pathway WP2875	1/32	0.11478607601940617	0.23741539683623286	0	0	8.556129032258065	18.52132495692828	ALAS1
Monoamine Transport WP727	1/32	0.11478607601940617	0.23741539683623286	0	0	8.556129032258065	18.52132495692828	FBXO32
Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839	1/32	0.11478607601940617	0.23741539683623286	0	0	8.556129032258065	18.52132495692828	GTPBP4
Signal transduction through IL1R WP4496	1/33	0.118155274306829	0.23741539683623286	0	0	8.288333333333334	17.701854626205957	TGFB2
Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786	1/33	0.118155274306829	0.23741539683623286	0	0	8.288333333333334	17.701854626205957	CRTAP
Fluoropyrimidine Activity WP1601	1/33	0.118155274306829	0.23741539683623286	0	0	8.288333333333334	17.701854626205957	RRM2
Regucalcin in proximal tubule epithelial kidney cells WP4838	1/33	0.118155274306829	0.23741539683623286	0	0	8.288333333333334	17.701854626205957	APAF1
Type 2 papillary renal cell carcinoma WP4241	1/34	0.1215118172783869	0.23741539683623286	0	0	8.036767676767676	16.939446916298973	TGFB2
Fatty acid beta-oxidation WP143	1/34	0.1215118172783869	0.23741539683623286	0	0	8.036767676767676	16.939446916298973	HADH
p38 MAPK Signaling Pathway WP400	1/34	0.1215118172783869	0.23741539683623286	0	0	8.036767676767676	16.939446916298973	TGFB2
Neovascularisation processes WP4331	1/37	0.13150598255242812	0.24458815992342522	0	0	7.365925925925926	14.943275535371535	TGFB2
Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850	1/37	0.13150598255242812	0.24458815992342522	0	0	7.365925925925926	14.943275535371535	FBXO32
Amyotrophic lateral sclerosis (ALS) WP2447	1/38	0.13481237161133675	0.24458815992342522	0	0	7.166486486486487	14.360716643585402	APAF1
Striated Muscle Contraction Pathway WP383	1/38	0.13481237161133675	0.24458815992342522	0	0	7.166486486486487	14.360716643585402	TMOD1
Parkinson's disease pathway WP2371	1/38	0.13481237161133675	0.24458815992342522	0	0	7.166486486486487	14.360716643585402	APAF1
Oxidative Damage WP3941	1/40	0.1413879282392794	0.2529051674139223	0	0	6.798290598290598	13.29914172209874	APAF1
Tryptophan metabolism WP465	1/42	0.14791416240366267	0.2553019418009951	0	0	6.4660162601626014	12.357353409839916	HADH
Fas ligand pathway and stress induction of heat shock proteins WP314	1/42	0.14791416240366267	0.2553019418009951	0	0	6.4660162601626014	12.357353409839916	APAF1
Vitamin A and carotenoid metabolism WP716	1/43	0.15115889773631005	0.2553019418009951	0	0	6.311746031746032	11.925562493804499	ALDH1A3
Vitamin D Receptor Pathway WP2877	2/182	0.15218653449643216	0.2553019418009951	0	0	2.9645645645645646	5.581232467056947	TGFB2;TRPV6
Nucleotide Excision Repair WP4753	1/44	0.1543914391423307	0.2553019418009951	0	0	6.1646511627906975	11.5171963880252	RPA1
Ras signaling WP4223	2/184	0.15483245853871308	0.2553019418009951	0	0	2.931689931689932	5.468808580096439	FGFR4;EPHA2
ATM Signaling Network in Development and Disease  WP3878	1/45	0.15761183181610405	0.2553019418009951	0	0	6.024242424242424	11.130510964997923	RNF20
Translation inhibitors in chronically activated PDGFRA cells WP4566	1/46	0.16082012081952446	0.2553019418009951	0	0	5.890074074074074	10.763926603538268	PIM1
Envelope proteins and their potential roles in EDMD physiopathology WP4535	1/46	0.16082012081952446	0.2553019418009951	0	0	5.890074074074074	10.763926603538268	TGFB2
Development of ureteric collection system WP5053	1/47	0.16401635102782586	0.25716143926585044	0	0	5.7617391304347825	10.416009512433067	TGFB2
Hepatitis C and Hepatocellular Carcinoma WP3646	1/49	0.1703728138367953	0.26387008972284154	0	0	5.521111111111111	9.771075944218465	RRM2
Copper homeostasis WP3286	1/52	0.17981817983779372	0.27298853311089255	0	0	5.195555555555556	8.914581245175166	SLC31A2
IL-4 signaling pathway WP395	1/54	0.1860560525481816	0.27298853311089255	0	0	4.998993710691824	8.406844180342443	FLNA
The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879	1/55	0.18915740876975234	0.27298853311089255	0	0	4.906172839506173	8.169640086306519	TGFB2
DNA IR-double strand breaks and cellular response via ATM WP3959	1/55	0.18915740876975234	0.27298853311089255	0	0	4.906172839506173	8.169640086306519	APAF1
RANKL/RANK signaling pathway WP2018	1/55	0.18915740876975234	0.27298853311089255	0	0	4.906172839506173	8.169640086306519	PAPSS2
Hematopoietic Stem Cell Differentiation WP2849	1/55	0.18915740876975234	0.27298853311089255	0	0	4.906172839506173	8.169640086306519	PIM1
Proximal tubule transport WP4917	1/57	0.19532517804728688	0.27872244507871274	0	0	4.730476190476191	7.7252911364805	CA2
Genotoxicity pathway WP4286	1/63	0.21355203631459144	0.29660801481801496	0	0	4.271397849462366	6.594503270757979	FBXO22
Endochondral Ossification with Skeletal Dysplasias WP4808	1/64	0.21654997777892615	0.29660801481801496	0	0	4.203386243386244	6.430903167126818	TGFB2
Endochondral Ossification WP474	1/64	0.21654997777892615	0.29660801481801496	0	0	4.203386243386244	6.430903167126818	TGFB2
Oncostatin M Signaling Pathway WP2374	1/65	0.21953664088892447	0.29660801481801496	0	0	4.1375	6.273426994160108	CYR61
Pathways affected in adenoid cystic carcinoma WP3651	1/65	0.21953664088892447	0.29660801481801496	0	0	4.1375	6.273426994160108	FGFR4
p53 transcriptional gene network WP4963	1/67	0.2254762993301082	0.3014262106834078	0	0	4.011717171717172	5.975614111882971	APAF1
DNA damage response WP707	1/68	0.22842937794204438	0.3021930312358296	0	0	3.9516417910447763	5.834710479551735	APAF1
Sterol regulatory element-binding proteins (SREBP) signaling WP1982	1/69	0.23137134471858622	0.30292949256969537	0	0	3.8933333333333335	5.698793885846119	SCD
miRNA regulation of DNA damage response WP1530	1/71	0.23722210773391983	0.307420486553141	0	0	3.7817142857142856	5.4409732451783235	APAF1
Chromosomal and microsatellite instability in colorectal cancer  WP4216	1/73	0.24302891658145068	0.31176436773580035	0	0	3.676296296296296	5.200396261462457	TGFB2
Prolactin Signaling Pathway WP2037	1/76	0.2516574279051145	0.31960493343949536	0	0	3.528711111111111	4.868515186094229	FLNA
Alzheimer's disease WP2059	1/83	0.2714149696079129	0.3349955360233141	0	0	3.2263414634146343	4.207492473945197	APAF1
Apoptosis WP254	1/84	0.27419512618527225	0.3349955360233141	0	0	3.187309236947791	4.124108145071636	APAF1
MicroRNAs in cardiomyocyte hypertrophy WP1544	1/84	0.27419512618527225	0.3349955360233141	0	0	3.187309236947791	4.124108145071636	RCAN1
Pathways in clear cell renal cell carcinoma WP4018	1/85	0.2769648132476219	0.3349955360233141	0	0	3.149206349206349	4.043155207554468	TGFB2
Pyrimidine metabolism WP4022	1/85	0.2769648132476219	0.3349955360233141	0	0	3.149206349206349	4.043155207554468	RRM2
Pancreatic adenocarcinoma pathway WP4263	1/89	0.28793964170883174	0.34498428770775125	0	0	3.0054545454545454	3.7418041277126273	TGFB2
Apoptosis Modulation and Signaling WP1772	1/90	0.290657561625685	0.34498607781740187	0	0	2.9715355805243444	3.6716575005112495	APAF1
TNF-alpha signaling pathway WP231	1/92	0.2960627247554384	0.34814783374019137	0	0	2.905934065934066	3.537056273283321	APAF1
Small cell lung cancer WP4658	1/96	0.3067514046072819	0.35740759986353027	0	0	2.783017543859649	3.2887408583424422	APAF1
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932	2/303	0.32025098952601944	0.3697443242709497	0	0	1.7619646224297387	2.006261454922708	FGFR4;EPHA2
Genes related to primary cilium development (based on CRISPR) WP4536	1/103	0.32507255139463415	0.37192985610016704	0	0	2.591111111111111	2.9116493992557615	TCTN3
ESC Pluripotency Pathways WP3931	1/116	0.3578387479929257	0.4057635803134068	0	0	2.2966956521739132	2.360251694459573	FGFR4
Osteoblast differentiation WP4787	1/118	0.36273837833357625	0.40767941635720517	0	0	2.2572079772079774	2.288974625300035	FGFR4
DNA Repair Pathways Full Network WP4946	1/120	0.3676011130846004	0.40952053826091445	0	0	2.219047619047619	2.220727128599108	RPA1
PI3K-Akt signaling pathway WP4172	2/340	0.3714117374233475	0.41016774480665336	0	0	1.5661282584359508	1.5511623796737937	FGFR4;EPHA2
Ebola Virus Pathway on Host WP4217	1/129	0.38903414014643084	0.4226409805849194	0	0	2.0620833333333333	1.946788491570107	FLNA
Adipogenesis WP236	1/130	0.3913708781373562	0.4226409805849194	0	0	2.0459948320413437	1.9193469972491382	SCD
Angiopoietin Like Protein 8 Regulatory Pathway WP3915	1/132	0.39601792668980634	0.4226409805849194	0	0	2.014554707379135	1.8660735629729877	SCD
TGF-beta Signaling Pathway WP366	1/132	0.39601792668980634	0.4226409805849194	0	0	2.014554707379135	1.8660735629729877	KLF10
Ectoderm Differentiation WP2858	1/138	0.40975000270027484	0.4336520861911242	0	0	1.925742092457421	1.7181626062965698	PIM1
Regulation of Actin Cytoskeleton WP51	1/150	0.43629639306131807	0.45793092494865617	0	0	1.7695749440715884	1.467744679196572	FGFR4
Epithelial to mesenchymal transition in colorectal cancer WP4239	1/160	0.4575156048048205	0.4762662443460016	0	0	1.6574423480083857	1.2960275733751492	TGFB2
Metapathway biotransformation Phase I and II WP702	1/183	0.5033743988036357	0.5155528116779171	0	0	1.4463003663003664	0.9927710220421859	GLYATL2
Ciliopathies WP4803	1/183	0.5033743988036357	0.5155528116779171	0	0	1.4463003663003664	0.9927710220421859	TCTN3
Focal Adhesion WP306	1/198	0.5311986116109761	0.5396977893967517	0	0	1.335160744500846	0.8446484482402136	FLNA
Circadian rhythm related genes WP3594	1/201	0.5365759520048036	0.540834491306429	0	0	1.3149333333333333	0.81860800895675	KLF10
IL-18 signaling pathway WP4754	1/272	0.6474843116692787	0.6474843116692787	0	0	0.9669372693726938	0.4202896446569869	HADH
